Novel cell-based and gene therapies represent promising approaches for the treatment of incurable diseases,including cancer. Following the success of the hematopoietic stem cell-based transplantation, other populationsof adult progenitor cells, including mesenchymal stem cells (MSCs), have been identified as powerful therapeutictools in humans. The intrinsic capability of MSCs to migrate toward injured tissues emphasizes theirsuitability to deliver anticancer agents for new clinical applications in addition to the tissue repairing capacity.Here, we revisit the experimental history of MSCs, the most exciting features of their biology in keeping withtheir promising applications in cell-based therapeutic strategies for cancer treatment.
Novel cell-based and gene therapies represent promising approaches for the treatment of incurable diseases, including cancer. Following the success of the hematopoietic stem cell-based transplantation, other populations of adult progenitor cells, including mesenchymal stem cells (MSCs), have been identified as powerful therapeutic tools in humans. The intrinsic capability of MSCs to migrate toward injured tissues emphasizes their suitability to deliver anticancer agents for new clinical applications in addition to the tissue repairing capacity. Here, we revisit the experimental history of MSCs, the most exciting features of their biology in keeping with their promising applications in cell-based therapeutic strategies for cancer treatment. © 2011 Mary Ann Liebert, Inc.
Mesenchymal stem cells: a new promise in anti-cancer therapy / Ciavarella, Sabino; Dominici, Massimo; Dammacco, Franco; Silvestris, Franco. - In: STEM CELLS AND DEVELOPMENT. - ISSN 1547-3287. - STAMPA. - 20:1(2011), pp. 1-10. [10.1089/scd.2010.0223]
Mesenchymal stem cells: a new promise in anti-cancer therapy
DOMINICI, Massimo;
2011
Abstract
Novel cell-based and gene therapies represent promising approaches for the treatment of incurable diseases, including cancer. Following the success of the hematopoietic stem cell-based transplantation, other populations of adult progenitor cells, including mesenchymal stem cells (MSCs), have been identified as powerful therapeutic tools in humans. The intrinsic capability of MSCs to migrate toward injured tissues emphasizes their suitability to deliver anticancer agents for new clinical applications in addition to the tissue repairing capacity. Here, we revisit the experimental history of MSCs, the most exciting features of their biology in keeping with their promising applications in cell-based therapeutic strategies for cancer treatment. © 2011 Mary Ann Liebert, Inc.File | Dimensione | Formato | |
---|---|---|---|
Ciavarella & Dominici Stem Cells Dev 2011_OK.pdf
Accesso riservato
Tipologia:
Versione pubblicata dall'editore
Dimensione
244.78 kB
Formato
Adobe PDF
|
244.78 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris